References
1. Suri V AA. Management of endometrial cancer. Vol. 106, Obstetrics and
Gynecology. 2005. p. 413–25.
2. Endometrial cancer statistics | World Cancer Research Fund
[Internet]. [cited 2020 Jan 13]. Available from:
https://www.wcrf.org/dietandcancer/cancer-trends/endometrial-cancer-statistics
3. Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: A
modern approach to surgical staging. Vol. 12, JNCCN Journal of the
National Comprehensive Cancer Network. Harborside Press; 2014. p.
288–97.
4. Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman LD, et al.
Prognosis of women with stage I endometrioid endometrial cancer and
synchronous stage I endometrioid ovarian cancer. Gynecol Oncol. 2017 Dec
1;147(3):558–64.
5. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martón A,
Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial
cancer: Diagnosis, treatment and follow-up. Ann Oncol. 2016 Jan
1;27(1):16–41.
6. Rajkumar S, Nath R, Lane G, Mehra G, Begum S, Sayasneh A. Advanced
stage (IIIC/IV) endometrial cancer: Role of cytoreduction and
determinants of survival. Eur J Obstet Gynecol Reprod Biol. 2019
Mar;234:26–31.
7. Buda A, Restaino S, Di Martino G, De Ponti E, Monterossi G, Dinoi G,
et al. The impact of the type of nodal assessment on prognosis in
patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group
endometrial cancer. A multicenter Italian study. Eur J Surg Oncol. 2018
Oct 1;44(10):1562–7.
8. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS.
Prognostic factors associated with recurrence in clinical stage I
adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78(1):63–9.
9. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, et
al. MRI, PET/CT and ultrasound in the preoperative staging of
endometrial cancer - a multicenter prospective comparative study.
Gynecol Oncol. 2013 Feb;128(2):300–8.
10. Haldorsen IS, Salvesen HB. What Is the Best Preoperative Imaging for
Endometrial Cancer? Vol. 18, Current Oncology Reports. Current Medicine
Group LLC 1; 2016. p. 1–11.
11. Epstein E, Blomqvist L. Imaging in endometrial cancer. Best Pract
Res Clin Obstet Gynaecol. 2014;
12. Zhu M, Jia N, Huang F, Liu X, Zhao Y, Tao X, et al. Whether
intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer
patients with lesions larger than 2 cm warrant lymph node dissection?
BMC Cancer. 2017 Oct 23;17(1).
13. Bendifallah S, Koskas M, Ballester M, Genin AS, Darai E, Rouzier R.
The survival impact of systematic lymphadenectomy in endometrial cancer
with the use of propensity score matching analysis. Am J Obstet Gynecol.
2012;206(6):500.e1-500.e11.
14. Ghanem AI, Khan NT, Mahan M, Ibrahim A, Buekers T, Elshaikh MA. The
impact of lymphadenectomy on survival endpoints in women with early
stage uterine endometrioid carcinoma: A matched analysis. Eur J Obstet
Gynecol Reprod Biol. 2017 Mar 1;210:225–30.
15. Critical Appraisal Skills Programme. CASP Qualitative Checklist.
Casp. 2018;
16. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et
al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and
Explanation. Ann Intern Med. 2018 Oct 2;169(7):467.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et
al. Preferred reporting items for systematic reviews and meta-analyses:
The PRISMA statement. Vol. 6, PLoS Medicine. 2009.
18. Todo Y, Watari H, Kang S, Sakuragi N. Tailoring lymphadenectomy
according to the risk of lymph node metastasis in endometrial cancer. J
Obstet Gynaecol Res. 2014 Feb;40(2):317–21.
19. Pecorelli S. Revised FIGO staging for carcinoma of the vulva,
cervix, and endometrium. Vol. 105, International journal of gynaecology
and obstetrics: the official organ of the International Federation of
Gynaecology and Obstetrics. 2009. p. 103–4.
20. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer
(MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–36.
21. Kim HS, Kim HY, Park CY, Lee JM, Lee JK, Cho CH, et al.
Lymphadenectomy increases the prognostic value of the revised 2009 FIGO
staging system for endometrial cancer: A multi-center study. Eur J Surg
Oncol. 2012 Mar;38(3):230–7.
22. Lucic N, Draganovic D, Sibincic S, Ecim-Zlojutro V, Milicevic S.
Myometrium Invasion, Tumour Size and Lymphovascular Invasion as a
Prognostic Factor in Dissemination of Pelvic Lymphatics at Endometrial
Carcinoma. Med Arch (Sarajevo, Bosnia Herzegovina). 2017 Oct
1;71(5):325–9.
23. Mahdi H, Jernigan A, Nutter B, Michener C, Rose PG. Lymph node
metastasis and pattern of recurrence in clinically early stage
endometrial cancer with positive lymphovascular space invasion. J
Gynecol Oncol. 2015 Jul 1;26(3):208–13.
24. Tomisato S, Yamagami W, Susumu N, Kuwahata M, Takigawa A, Nomura H,
et al. Clinicopathological study on para-aortic lymph node metastasis
without pelvic lymph node metastasis in endometrial cancer. J Obstet
Gynaecol Res. 2014 Jun;40(6):1733–9.
25. Polterauer S, Khalil S, Zivanovic O, Abu-Rustum NR, Hofstetter G,
Concin N, et al. Prognostic Value of Lymph Node Ratio and
Clinicopathologic Parameters in Patients Diagnosed With Stage IIIC
Endometrial Cancer. Obstet Gynecol. 2012 Jun;119(6):1210–8.
26. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012 Aug;120(2 PART
1):383–97.
27. Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML,
et al. Association of number of positive nodes and cervical stroma
invasion with outcome of advanced endometrial cancer treated with
chemotherapy or whole abdominal irradiation: A Gynecologic Oncology
Group study. Gynecol Oncol. 2012 Apr;125(1):87–93.
28. Bassarak N, Blankenstein T, Brüning A, Dian D, Bergauer F, Friese K,
et al. Is lymphadenectomy a prognostic marker in endometrioid
adenocarcinoma of the human endometrium? BMC Cancer. 2010 May 31;10.
29. Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the
management of endometrial cancer. Cochrane Database of Systematic
Reviews. 2017.
30. Coronado PJ, Rychlik A, Martínez-Maestre MA, Baquedano L, Fasero M,
García-Arreza A, et al. Role of lymphadenectomy in intermediate-risk
endometrial cancer: A matched-pair study. J Gynecol Oncol. 2018;
31. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C,
et al. The incidence of symptomatic lower-extremity lymphedema following
treatment of uterine corpus malignancies: A 12-year experience at
Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006
Nov;103(2):714–8.
32. Carlson JW, Kauderer J, Hutson A, Carter J, Armer JA, Lockwood S, et
al. GOG 244, the lymphedema and gynecologic cancer (LEG) study:
Incidence and risk factors in newly diagnosed patients. Gynecol Oncol.
2018 Jun;149:6–7.
33. Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N,
Manuzzi L, et al. Controversies in Surgical Staging of Endometrial
Cancer. Obstet Gynecol Int. 2010;2010:1–8.
34. Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia
G, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in
early-stage endometrial carcinoma: Randomized clinical trial. J Natl
Cancer Inst. 2008;
35. Oncoguía SEGO: Cáncer de Endometrio 2010. Guías de práctica clínica
en cáncer ginecológico y mamario. Publicaciones SEGO, Octubre 2010.
36. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al.
Therapeutic role of lymph node resection in endometrioid corpus cancer:
a study of 12,333 patients. Cancer. 2006 Oct 15;107(8):1823–30.
37. Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin
O, et al. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO
High–Intermediate Risk Endometrial Cancer: A Multicentre Cohort
Analysis from the FRANCOGYN Study Group. Ann Surg Oncol. 2017 Jun
1;24(6):1660–6.
38. Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, et al.
Lymphadenectomy in endometrioid uterine cancer staging: How many lymph
nodes are enough? A study of 11,443 patients. Cancer. 2007 Jun
15;109(12):2454–60.
39. Multinu F, Ducie JA, Eriksson AGZ, Schlappe BA, Cliby WA, Glaser GE,
et al. Role of lymphadenectomy in endometrial cancer with nonbulky lymph
node metastasis: Comparison of comprehensive surgical staging and
sentinel lymph node algorithm. Gynecol Oncol. 2019 Nov 1;155(2):177–85.
40. Santaballa A, Matías-Guiu X, Redondo A, Carballo N, Gil M, Gómez C,
et al. SEOM clinical guidelines for endometrial cancer (2017). Clin
Transl Oncol. 2018 Jan 1;20(1):29–37.
41. Shih KK, Yun E, Gardner GJ, Barakat RR, Chi DS, Leitao MM. Surgical
cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol
Oncol. 2011 Sep;122(3):608–11.
42. Havrilesky LJ, Cragun JM, Calingaert B, Synan I, Secord AA, Soper
JT, et al. Resection of lymph node metastases influences survival in
stage IIIC endometrial cancer. Gynecol Oncol. 2005 Dec;99(3):689–95.
43. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role
of para-aortic lymphadenectomy in node-positive endometrial cancer.
Gynecol Oncol. 2000 Mar;76(3):348–56.
44. Numazaki R, Miyagi E, Konnai K, Ikeda M, Yamamoto A, Onose R, et al.
Analysis of stage IVB endometrial carcinoma patients with distant
metastasis: A review of prognoses in 55 patients. Int J Clin Oncol. 2009
Aug;14(4):344–50.
45. Ueda Y, Enomoto T, Miyatake T, Egawa-Takata T, Ugaki H, Yoshino K,
et al. Endometrial carcinoma with extra-abdominal metastasis: Improved
prognosis following cytoreductive surgery. Ann Surg Oncol. 2010
Apr;17(4):1111–7.
46. Salehi S, Brandberg Y, Åvall-Lundqvist E, Suzuki C, Johansson H,
Legerstam B, et al. Long-term quality of life after comprehensive
surgical staging of high-risk endometrial cancer–results from the
RASHEC trial. Acta Oncol (Madr). 2018 Dec 2;57(12):1671–6.
47. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et
al. Prospective assessment of lymphatic dissemination in endometrial
cancer: A paradigm shift in surgical staging. Gynecol Oncol. 2008
Apr;109(1):11–8.
48. Fotopoulou C, El-Balat A, du Bois A, Sehouli J, Harter P, Muallem
MZ, et al. Systematic pelvic and paraaortic lymphadenectomy in early
high-risk or advanced endometrial cancer. Arch Gynecol Obstet. 2015 Dec
1;292(6):1321–7.
49. Polan RM, Rossi EC, Barber EL. Extent of lymphadenectomy and
postoperative major complications among women with endometrial cancer
treated with minimally invasive surgery. Am J Obstet Gynecol. 2019 Mar
1;220(3):263.e1-263.e8.
50. Lim PC, Kang E, Park DH. A comparative detail analysis of the
learning curve and surgical outcome for robotic hysterectomy with
lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in
treatment of endometrial cancer: A case-matched controlled study of the
first one hundred twenty two patients. Gynecol Oncol. 2011
Mar;120(3):413–8.
51. Johnson L, Bunn WD, Nguyen L, Rice J, Raj M, Cunningham MJ. Clinical
comparison of robotic, laparoscopic, and open hysterectomy procedures
for endometrial cancer patients. J Robot Surg. 2017 Sep 1;11(3):291–7.
52. Cardenas-Goicoechea J, Soto E, Chuang L, Gretz H, Randall TC.
Integration of robotics into two established programs of minimally
invasive surgery for endometrial cancer appears to decrease surgical
complications. J Gynecol Oncol. 2012;24(1):21–8.
53. Sarlos D, Kots LA. Robotic versus laparoscopic hysterectomy: A
review of recent comparative studies. Vol. 23, Current Opinion in
Obstetrics and Gynecology. 2011. p. 283–8.
54. Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS, et
al. Minimally invasive comprehensive surgical staging for endometrial
cancer: Robotics or laparoscopy? Gynecol Oncol. 2009 Apr;113(1):36–41.
55. Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN,
et al. A comparative study of 3 surgical methods for hysterectomy with
staging for endometrial cancer: robotic assistance, laparoscopy,
laparotomy. Am J Obstet Gynecol. 2008;199(4):360.e1-360.e9.
56. Khoury-Collado F, St. Clair C, Abu-Rustum NR. Sentinel Lymph Node
Mapping in Endometrial Cancer: An Update. Oncologist. 2016
Apr;21(4):461–6.
57. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests
for lymph node status in primary endometrial cancer. BMC Womens Health.
2008 May 5;8:8.
58. Zahl Eriksson AG, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, et
al. Comparison of a sentinel lymph node and a selective lymphadenectomy
algorithm in patients with endometrioid endometrial carcinoma and
limited myometrial invasion. Gynecol Oncol. 2016 Mar;140(3):394–9.
59. Tanner EJ, Ojalvo L, Stone RL, Levinson K, Temkin SM, Murdock T, et
al. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial
Cancer. Int J Gynecol Cancer. 2017;27(7):1416–21.
60. Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK,
et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for
endometrial cancer staging (FIRES trial): a multicentre, prospective,
cohort study. Lancet Oncol. 2017;18(3):384–92.
61. Bedyńska M, Szewczyk G, Klepacka T, Sachadel K, Maciejewski T,
Szukiewicz D, et al. Sentinel lymph node mapping using indocyanine green
in patients with uterine and cervical neoplasms: restrictions of the
method. Arch Gynecol Obstet. 2019 May;299(5):1373–84.